Russian COVID-19 vaccine in India: Russia seeks collaboration for manufacturing Sputnik V: sources
The Russian government has reached out to India seeking a collaboration for manufacturing its COVID-19 vaccine ‘Sputnik V’ and conducting its phase 3 clinical trial here,
By IAR Desk
The Russian government has reached out to India seeking a collaboration for manufacturing its COVID-19 vaccine ‘Sputnik V’ and conducting its phase 3 clinical trial here, the Press Trust of India has reported. The matter was apparently discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22.
Citing government sources the news agency reported that while there has been scepticism in some quarters about limited data related to the efficacy of the vaccine, “The Russian government has reached out to the Indian government seeking a collaboration for manufacturing their COVID-19 vaccine, Sputnik V, and conducting its phase 3 trial here.” The vaccine has not been tested in phase 3 or larger clinical trials.
“The Department of Biotechnology (DBT) along with the Department of Health Research has been asked to lead and look into the matter. They (Russian government officials) have shared some information and data on Sputnik V, while more data related to the safety and efficacy of the vaccine is awaited,” the source told PTI.
According to the news agency, when asked if the Russian government has placed any formal request for the manufacture of its COVID-19 vaccine in India, Union Health Secretary Rajesh Bhushan said at a press conference, “As far as Sputnik V vaccine is concerned, both India and Russia are in communication. Some initial information has been shared while some detailed information is awaited.”
PTI also reported that Russian Ambassador to India Nikolay Kudashev has approached the office of Principal Scientific Advisor K Vijay Raghavan as well as secretaries of the departments of biotechnology and health research in this regard.
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund (RDIF).
